Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
D000932:Antiemetics / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D005769:Gastrointestinal Motility / Q000187:drug effects; D041981:Gastrointestinal Tract / Q000294:innervation*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy
D000932:Antiemetics; D015259:Dopamine Agents; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists